Emmanuel Brouillet

After a doctorate in neuropharmacology at the University of Paris, Dr. Brouillet obtained a post-doctoral fellowship to study the pathogenesis of Huntington's disease at the neurology department of Massachusetts General Hospital (Harvard Medical School) where he worked with the Professor M. Flint Beal. Since joining the C.N.R.S. in 1993, he has devoted his career to studying the pathogenesis of age-related neurodegenerative diseases, in particular Huntington's, Parkinson's, and Alzheimer's diseases. He has also launched research projects on new experimental therapies and brain imaging. Dr. Brouillet is now research director at the C.N.R.S. and after more than ten years as director of the Neurodegenerative Diseases Laboratory at the C.E.A. near Paris, he recently joined a new research team at Sorbonne University to develop his research on the role of molecular mechanisms of aging in Huntington’s disease. He is the co-author of more than 150 peer-reviewed publications and a member of numerous local and international scientific committees and councils of governmental and charitable organizations dedicated to patients with neurodegenerative diseases. Since 2020, he is Head of the Europe and International Office of the Institute of Biological Sciences of the C.N.R.S, which brings together more than 200 laboratories and collaborative networks.

Email: emmanuel.brouillet@cnrs.fr